NOVO-B.CO
Eli Lilly wins FDA heart approval for Mounjaro, intensifying Novo Nordisk rivalry
The FDA approved Eli Lilly’s Mounjaro to reduce risks of heart attack, stroke, and cardiovascular death in high-risk adults with type 2 diabetes. This decision...
